SK11472002A3 - Zlúčeniny užitočné na liečbu alebo prevenciu chorôb sprostredkovaných alfa-2B-adrenoceptormi - Google Patents
Zlúčeniny užitočné na liečbu alebo prevenciu chorôb sprostredkovaných alfa-2B-adrenoceptormi Download PDFInfo
- Publication number
- SK11472002A3 SK11472002A3 SK1147-2002A SK11472002A SK11472002A3 SK 11472002 A3 SK11472002 A3 SK 11472002A3 SK 11472002 A SK11472002 A SK 11472002A SK 11472002 A3 SK11472002 A3 SK 11472002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alpha
- disease
- adrenoceptor
- antagonist
- selective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18202100P | 2000-02-11 | 2000-02-11 | |
| FI20000303A FI20000303A0 (fi) | 2000-02-14 | 2000-02-14 | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
| PCT/FI2001/000105 WO2001058454A1 (en) | 2000-02-11 | 2001-02-07 | Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK11472002A3 true SK11472002A3 (sk) | 2003-02-04 |
Family
ID=26160944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1147-2002A SK11472002A3 (sk) | 2000-02-11 | 2001-02-07 | Zlúčeniny užitočné na liečbu alebo prevenciu chorôb sprostredkovaných alfa-2B-adrenoceptormi |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1253926A1 (es) |
| JP (1) | JP2003522148A (es) |
| KR (1) | KR20020080413A (es) |
| AU (1) | AU780802B2 (es) |
| BR (1) | BR0108221A (es) |
| CA (1) | CA2399421A1 (es) |
| CZ (1) | CZ20022884A3 (es) |
| EA (1) | EA200200846A1 (es) |
| EE (1) | EE200200435A (es) |
| GE (1) | GEP20043356B (es) |
| HR (1) | HRP20020746A2 (es) |
| HU (1) | HUP0300032A3 (es) |
| IL (1) | IL151017A0 (es) |
| IS (1) | IS6476A (es) |
| MX (1) | MXPA02007454A (es) |
| MY (1) | MY133957A (es) |
| NO (1) | NO20023773D0 (es) |
| NZ (1) | NZ520500A (es) |
| PL (1) | PL357872A1 (es) |
| SK (1) | SK11472002A3 (es) |
| WO (1) | WO2001058454A1 (es) |
| YU (1) | YU59102A (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04000615A (es) * | 2001-07-20 | 2004-04-20 | Juvantia Pharma Ltd Oy | Compuestos utiles para el tratamiento o la prevencion de enfermedades mediadas por alfa-2b-adrenoceptor. |
| FI116940B (fi) | 2001-07-20 | 2006-04-13 | Juvantia Pharma Ltd Oy | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8416432D0 (en) * | 1984-06-28 | 1984-08-01 | Wyeth John & Brother Ltd | Benzoquinolizines |
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| US6150389A (en) * | 1994-07-11 | 2000-11-21 | Allergan Sales, Inc. | Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents |
-
2001
- 2001-02-07 IL IL15101701A patent/IL151017A0/xx unknown
- 2001-02-07 CZ CZ20022884A patent/CZ20022884A3/cs unknown
- 2001-02-07 WO PCT/FI2001/000105 patent/WO2001058454A1/en not_active Application Discontinuation
- 2001-02-07 GE GE4893A patent/GEP20043356B/en unknown
- 2001-02-07 MX MXPA02007454A patent/MXPA02007454A/es unknown
- 2001-02-07 KR KR1020027010329A patent/KR20020080413A/ko not_active Application Discontinuation
- 2001-02-07 CA CA002399421A patent/CA2399421A1/en not_active Abandoned
- 2001-02-07 EP EP01907585A patent/EP1253926A1/en not_active Withdrawn
- 2001-02-07 AU AU35510/01A patent/AU780802B2/en not_active Ceased
- 2001-02-07 SK SK1147-2002A patent/SK11472002A3/sk unknown
- 2001-02-07 JP JP2001557564A patent/JP2003522148A/ja active Pending
- 2001-02-07 EA EA200200846A patent/EA200200846A1/ru unknown
- 2001-02-07 PL PL01357872A patent/PL357872A1/xx not_active Application Discontinuation
- 2001-02-07 YU YU59102A patent/YU59102A/sh unknown
- 2001-02-07 BR BR0108221-3A patent/BR0108221A/pt not_active IP Right Cessation
- 2001-02-07 EE EEP200200435A patent/EE200200435A/xx unknown
- 2001-02-07 HU HU0300032A patent/HUP0300032A3/hu unknown
- 2001-02-07 NZ NZ520500A patent/NZ520500A/en unknown
- 2001-02-09 MY MYPI20010579A patent/MY133957A/en unknown
-
2002
- 2002-07-19 IS IS6476A patent/IS6476A/is unknown
- 2002-08-09 NO NO20023773A patent/NO20023773D0/no not_active Application Discontinuation
- 2002-09-11 HR HRP20020746 patent/HRP20020746A2/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU780802B2 (en) | 2005-04-21 |
| EE200200435A (et) | 2003-12-15 |
| HUP0300032A2 (en) | 2003-05-28 |
| EA200200846A1 (ru) | 2002-12-26 |
| CZ20022884A3 (cs) | 2003-02-12 |
| WO2001058454A1 (en) | 2001-08-16 |
| GEP20043356B (en) | 2004-04-13 |
| EP1253926A1 (en) | 2002-11-06 |
| HRP20020746A2 (en) | 2004-12-31 |
| BR0108221A (pt) | 2003-03-05 |
| HUP0300032A3 (en) | 2006-01-30 |
| AU3551001A (en) | 2001-08-20 |
| KR20020080413A (ko) | 2002-10-23 |
| NZ520500A (en) | 2005-01-28 |
| MY133957A (en) | 2007-11-30 |
| JP2003522148A (ja) | 2003-07-22 |
| YU59102A (sh) | 2005-11-28 |
| CA2399421A1 (en) | 2001-08-16 |
| NO20023773L (no) | 2002-08-09 |
| IL151017A0 (en) | 2003-02-12 |
| PL357872A1 (en) | 2004-07-26 |
| NO20023773D0 (no) | 2002-08-09 |
| MXPA02007454A (es) | 2004-08-23 |
| IS6476A (is) | 2002-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Frishman et al. | Serotonin and serotonin antagonism in cardiovascular and non‐cardiovascular disease | |
| Frishman et al. | Serotonin and the heart | |
| ES2365161T3 (es) | Terapia para el tratamiento de la vejiga hiperactiva. | |
| US20210401822A1 (en) | Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl[-benzamide | |
| Yatsu et al. | Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs | |
| JP6250280B2 (ja) | 腎疾患の治療のための組成物及び方法 | |
| KR20070099527A (ko) | 유기 화합물의 조합물 | |
| KR20070005911A (ko) | 개선된 비-진정성 알파-2 효능제의 신규 동정 방법 | |
| JP2010514696A (ja) | 心血管症状の低減 | |
| Salomonsson et al. | α1-Adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies | |
| Katayama et al. | Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM) | |
| Gentili et al. | Agonists and antagonists targeting the different α2-adrenoceptor subtypes | |
| AU766814B2 (en) | Imidazoline receptor binding compounds | |
| WO2022095461A1 (zh) | 一种特异性增强TRPV4-KCa2.3复合体的空间耦联度的化合物及其用途 | |
| SK11472002A3 (sk) | Zlúčeniny užitočné na liečbu alebo prevenciu chorôb sprostredkovaných alfa-2B-adrenoceptormi | |
| US6521632B2 (en) | Method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor | |
| US6174917B1 (en) | Method of treating liver disease and like indications with vasodilating agents | |
| Pergolini | The management of hypertensive crises: a clinical review | |
| US6767909B2 (en) | Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor | |
| JP2765698B2 (ja) | アリールアルキルアミド含有の神経変性疾患治療剤 | |
| JP2004535467A (ja) | α−２Ｂ−アドレナリン受容体が介在する疾患を治療又は予防するために有用な化合物 | |
| Drew et al. | The relationships between the cardiovascular effects, α-and β-adrenoceptor blocking actions and plasma concentration of labetalol in DOCA hypertensive rats | |
| NAGATOMO et al. | Effect of 3-[2-[4-(o-Methoxyphenyl)-1-piperazinyl] ethyl]-2, 4 (1H, 3H)-quinazolinedione Monohydrochloride (SGB-1534), an Anthihypertensive Agent, on 3H-Prazosin and 3H-p-Aminoclonidine Binding to α1-and α2-Adrenoceptors in Dog Brain and Arta | |
| Baldwin et al. | Antihypertensive agents | |
| RU2494738C2 (ru) | Применение ингибиторов пкс при трансплантации |